These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2421080)

  • 1. [Use of the determination of the blood serum levels of middle molecules for screening azotemia].
    Titel'man KM; Mustafaeva TM; Ianovskaia IK
    Lab Delo; 1986; (3):143-5. PubMed ID: 2421080
    [No Abstract]   [Full Text] [Related]  

  • 2. [Content of middle mass molecules in blood serum of patients with burns after hemosorption treatment].
    Markelov IM; Vikhriev BS; Tupikova ZA; Kuznetsova LA
    Vopr Med Khim; 1983; 29(3):105-8. PubMed ID: 6880111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum middle molecules in uremia.
    Buzio C; Manari A; Calderini C; Montagna G; Migone L
    Artif Organs; 1981; 4 Suppl():143-50. PubMed ID: 7295081
    [No Abstract]   [Full Text] [Related]  

  • 4. [Middle molecule levels in patients with spinal cord trauma].
    Petrova NV; Eroshkina TD
    Vopr Med Khim; 1994; 40(5):53-5. PubMed ID: 7839674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Middle molecules in hepatic coma and uremia.
    Chang TM; Lister C
    Artif Organs; 1981; 4 Suppl():169-72. PubMed ID: 7295086
    [No Abstract]   [Full Text] [Related]  

  • 6. "Middle molecules" in acute experimental uremia.
    Lutz W; Madry K; Grande G
    Acta Med Pol; 1978; 19(4):417-24. PubMed ID: 752244
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnostic value of determining middle molecules in the blood plasma in nephrological diseases].
    Gabriélian NI; Dmitriev AA; Kulakov GP; Melikian AM; Shcherbaneva OI
    Klin Med (Mosk); 1981 Oct; 59(10):38-42. PubMed ID: 7311409
    [No Abstract]   [Full Text] [Related]  

  • 8. Methodology for identification of serum middle molecules.
    Buzio C; Montagna G; Calderini C; Manari A; Migone L
    Artif Organs; 1981; 4 Suppl():22-7. PubMed ID: 7295090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of trasylol on the concentration of middle-sized molecules of urea and creatinine in the plasma in acute experimental uremia].
    Madry K; Lutz W; Grande G
    Pol Tyg Lek; 1978 Jan; 33(1):5-8. PubMed ID: 306100
    [No Abstract]   [Full Text] [Related]  

  • 10. ["Middle molecules" as nonspecific regulators of phagocyte activity].
    Volchegorskiĭ IA; Vlasov AV; Livshits GE; Akhkiamov EM; Skobeleva NA; Lifshits RI; Ebert LIa
    Biull Eksp Biol Med; 1995 Feb; 119(2):159-62. PubMed ID: 7670039
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of toxic activity of blood in uremia].
    Shumakov VI; Gabriélian NI; Shcherbaneva OI; Dmitriev AA; Mogireva IA
    Ter Arkh; 1980; 52(4):62-4. PubMed ID: 7404340
    [No Abstract]   [Full Text] [Related]  

  • 12. [Middle molecules and the problem of endogenous intoxication in critical states of various etiologies].
    Vladyka AS; Levitskiĭ ER; Poddubnaia LP; Gabriélian NI
    Anesteziol Reanimatol; 1987; (2):37-42. PubMed ID: 3300433
    [No Abstract]   [Full Text] [Related]  

  • 13. Analytical study for separation of middle molecules.
    Saito A; Kanazawa I; Chung TG; Maeda K
    Artif Organs; 1981; 4 Suppl():13-6. PubMed ID: 6975092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on uremic toxins--biochemical analysis of uremic serum (author's transl)].
    Gejyo F
    Nihon Jinzo Gakkai Shi; 1978 Mar; 20(3):199-214. PubMed ID: 353340
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of middle molecular weight fraction in the plasma of patients with uremia using high performance liquid chromatography and thin layer chromatography].
    Kovalishin IaF; Nikolaev VG; Baran EIa; Dudar' IA; Iushko LA
    Vopr Med Khim; 1988; 34(6):23-6. PubMed ID: 3238937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anemia of chronic renal failure: erythropoiesis and serum inhibitor(s) of erythroid progenitor cells in uremia].
    Urushiyama M; Moriyama Y
    Rinsho Ketsueki; 1985 May; 26(5):668-73. PubMed ID: 4057581
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
    Ringoir SM; van Landschoot N; de Smet R
    Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients.
    Popławski A; Myśliwiec M
    Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biochemical definition of uremia].
    Ringoir S
    Verh K Acad Geneeskd Belg; 1981; 43(2):105-19. PubMed ID: 7314875
    [No Abstract]   [Full Text] [Related]  

  • 20. A defense of the middle molecule hypothesis.
    Funck-Brentano JL; Cueille GF; Man NK
    Kidney Int Suppl; 1978 Jun; (8):S31-5. PubMed ID: 278894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.